Stock GUTS FRACTYL HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
6.74 USD +0.30% Intraday chart for Fractyl Health, Inc. -9.65% -.--%
May. 20 Fractyl Health, Inc. Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva At Digestive Disease Week 2024 CI
May. 13 Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000 MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
GL
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
GL
Fractyl Health, Inc. Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva At Digestive Disease Week 2024
CI
Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000
MT
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GL
Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes
MT
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
GL
Fractyl Health Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes
CI
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
GL
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
GL
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
GL
Fractyl Health Names Adrian Kimber Chief Commercial Officer; Shares Down
MT
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
GL
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
AQ
Fractyl Health, Inc. Announces Appointment of Adrian Kimber as Chief Commercial Officer
CI
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures
MT
Rising Rate Cut Hopes Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Monday
MT
Top Premarket Decliners
MT
Fractyl Health Shares Drop After Wider 4Q Loss
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUTS Stock
  4. News Fractyl Health, Inc.